Page last updated: 2024-08-24

draflazine and caffeine

draflazine has been researched along with caffeine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Abreu, RA; Rongen, GA; Smits, P; Thien, T; Van Belle, H; Ver Donck, K; Willemsen, JJ	1

Trials

1 trial(s) available for draflazine and caffeine

Article	Year
Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection. The Journal of clinical investigation, 1995, Volume: 95, Issue:2 Topics: Adenosine; Adult; Blood Pressure; Caffeine; Carrier Proteins; Cross-Over Studies; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Heart Rate; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Male; Membrane Proteins; Middle Aged; Norepinephrine; Nucleoside Transport Proteins; Piperazines; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Antagonists; Reference Values; Systole; Vasodilation	1995

Article

Year

Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection.

The Journal of clinical investigation, 1995, Volume: 95, Issue:2

Topics: Adenosine; Adult; Blood Pressure; Caffeine; Carrier Proteins; Cross-Over Studies; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Heart Rate; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Male; Membrane Proteins; Middle Aged; Norepinephrine; Nucleoside Transport Proteins; Piperazines; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Antagonists; Reference Values; Systole; Vasodilation

1995